date,title,source
Oct-17-18,Samsung launches third rival to AbbVie's Humira drug in EU,Reuters
Oct-17-18,"Biogen and Samsung Bioepis Announce European Launch of IMRALDI(adalimumab), Solidifying Leadership in European Anti-TNF Market",Business Wire
Oct-17-18,MIT researchers among winners of prestigious Breakthrough Prize,American City Business Journals
Oct-17-18,Samsung launches third rival to AbbVie's Humira drug in EU,Reuters
Oct-17-18,"Biogen and Samsung Bioepis Announce European Launch of IMRALDI(adalimumab), Solidifying Leadership in European Anti-TNF Market",Business Wire
Oct-18-18,Biogen to Present Data from Alzheimers Disease Portfolio at the 2018 Clinical Trials on Alzheimers Disease (CTAD) Meeting,GlobeNewswire
Oct-19-18,Biogen (BIIB) Q3 Earnings Coming Up: What's in the Cards?,Zacks
Oct-19-18,Alkermes Boasts Strong Portfolio and Impressive Pipeline,Zacks
Oct-19-18,"Stocks making the biggest move premarket: PG, HON, F, VFC, HOG AMZN & more",CNBC
Oct-22-18,Biogen earnings: Its all about upcoming Alzheimers disease results,MarketWatch
Oct-22-18,Biogen Q3 Earnings Outlook,Benzinga
Oct-22-18,"Analysts wary of Biogen's strategy as earnings, Alzheimer's data loom",American City Business Journals
Oct-22-18,"BIIB, ALKS Q3 Earnings Due on Oct 23: What's in Store?",Zacks
Oct-22-18,Biogen on Deck as Biotechs Face Make-or-Break Earnings Season,Bloomberg
Oct-23-18,Edited Transcript of BIIB earnings conference call or presentation 23-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Oct-23-18,Biogen Inc (BIIB) Q3 2018 Earnings Conference Call Transcript,Motley Fool
Oct-23-18,Biogen Earnings: 10 Highlights From BIIBs Q3,InvestorPlace
Oct-23-18,"Stocks - Caterpillar, 3M Tank in Pre-market; McDonalds, Verizon Gain",Investing.com
Oct-23-18,Biogen's Spinraza drives third-quarter profit beat,Reuters
Oct-23-18,Biogen's Spinraza drives third-quarter profit beat,Reuters
Oct-23-18,"Biogen (BIIB) Q3 Earnings & Sales Beat, Spinraza Shines",Zacks
Oct-23-18,Biogen stock rises 3% after Q3 profit and revenue beats,MarketWatch
Oct-23-18,"Biogen Inc Earnings, Revenue beat in Q3",Investing.com
Oct-23-18,Biogen (BIIB) Q3 Earnings & Sales Beat Estimates,Zacks
Oct-23-18,[$$] Biogen 3Q Profit Rises 18%,The Wall Street Journal
Oct-23-18,"Biogen, UCB study of lupus treatment fails primary endpoint",MarketWatch
Oct-23-18,Biogen third-quarter profit rises 17.8 pct,Reuters
Oct-23-18,"Stoke CEO weighs clinical trials, IPO and partnerships after $90M round",American City Business Journals
Oct-23-18,UCB and Biogen Announce Topline Results from a Phase 2b Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus,GlobeNewswire
Oct-24-18,Biogen Rides the Spinraza Wave to Double-Digit Growth,Motley Fool
Oct-24-18,Alkermes Makes Financial Progress as Its Pipeline Moves Forward,Motley Fool
Oct-24-18,"Biotech Stock Roundup: BIIB Tops, MACK Plunges, REGN's Asthma Drug Gets FDA Nod",Zacks
Oct-24-18,Forward Pharma loses appeal in Tecfidera patent dispute with Biogen,Reuters
Oct-24-18,Forward Pharma loses appeal in Tecfidera patent dispute with Biogen,Reuters
Oct-24-18,Forward Pharma loses appeal in Tecfidera patent dispute with Biogen,Reuters
Oct-24-18,Edited Transcript of BIIB earnings conference call or presentation 23-Oct-18 12:00pm GMT,Thomson Reuters StreetEvents
Oct-25-18,Biogen Stock Dips After Alzheimer's Results Show 'Thin' Impact,Investor's Business Daily
Oct-25-18,This experimental Alzheimers disease drug seemed promising  before the latest results left many unsure,MarketWatch
Oct-25-18,"Eisai, Biogen Alzheimer's data fails to convince skeptics",Reuters
Oct-25-18,Biogen analysts pounce on 'thin' Alzheimer's trial data,American City Business Journals
Oct-25-18,Biogen shares slip after Alzheimer's data fails to convince,Reuters
Oct-25-18,Biogen/Eisai Alzheimer's data suggests treatment effect related to drug,Reuters
Oct-25-18,Eisai and Biogen Announce Presentation of Additional Data From the Phase II Clinical Trial of BAN2401 in Early Alzheimers Disease at the 2018 Clinical Trials on Alzheimers Disease (CTAD) Conference,GlobeNewswire
Oct-25-18,"The Daily Biotech Pulse: AbbVie Takes Full Control Of Cystic Fibrosis Program, Amgen Slashes Cholesterol Drug Price",Benzinga
Oct-26-18,This experimental Alzheimers disease drug seemed promising  before the latest results left many unsure,MarketWatch
Oct-26-18,The October stock crash has wiped out $45.5B from Mass. health firms,American City Business Journals
Oct-26-18,"Top Research Reports for McDonald's, Thermo Fisher & Caterpillar",Zacks
Oct-26-18,Biogen and Eisai Announce Presentation of Detailed Analyses from the Phase 1b Long-Term Extension Study of Aducanumab at Clinical Trials on Alzheimers Disease (CTAD),GlobeNewswire
Oct-26-18,"The Daily Biotech Pulse: Gilead's Q2, Syndax Breast Cancer Drug Setback, Synergy Pharma On Brink Of Default",Benzinga
Oct-29-18,Biogen And Eisai May Be At Odds In Alzheimer's  So What Now?,Investor's Business Daily
Oct-29-18,"New Research Coverage Highlights Rite Aid, The Boeing, Cabot, Biogen, McDonald's, and Pegasystems  Consolidated Revenues, Company Growth, and Expectations for 2018",GlobeNewswire
Oct-31-18,Sarissa Capitals Alex Denner Bullish on Biogen (BIIB),Insider Monkey
Nov-01-18,Biotech ETFs in Focus on String of Q3 Earnings Beat,Zacks
Nov-05-18,Biogen Stock Rebounds After Impressive Q3 Earnings,InvestorPlace
Nov-06-18,"Ionis Pharmaceuticals, Inc. (IONS) Q3 2018 Earnings Conference Call Transcript",Motley Fool
Nov-07-18,7 Healthcare Stocks Soaring on Election Results,InvestorPlace
Nov-08-18,Jeff Auxier Comments on Biogen,GuruFocus.com
Nov-08-18,Jeff Auxier's Auxier Asset Management 3rd Quarter Commentary,GuruFocus.com
Nov-08-18,"Drug prices may be rising, but you can buy biotech stocks at rock-bottom levels",MarketWatch
Nov-09-18,6 Pharmaceutical Stocks to Buy After the Midterms,InvestorPlace
Nov-09-18,"Drug prices may be rising, but you can buy biotech stocks at rock-bottom levels",MarketWatch
Nov-12-18,5 Pharma Stocks to Stay Away From,InvestorPlace
Nov-12-18,An expensive new medication is finally available for her rare disease  but shes been fighting for two years to get it,MarketWatch
Nov-12-18,Ionis Pharmaceuticals Collects Royalties -- and Spends It All,Motley Fool
Nov-13-18,An expensive new medication is finally available for her rare disease  but shes been fighting for two years to get it,MarketWatch
Nov-14-18,"Drug prices may be rising, but you can buy biotech stocks at rock-bottom levels",MarketWatch
Nov-14-18,[$$] Possible delisting of BioLogics threatens Samsungs growth strategy,Financial Times
Nov-21-18,Should You Invest in the Invesco Dynamic Biotechnology & Genome ETF (PBE)?,Zacks
Nov-23-18,US benefits manager baulks after Novartis values gene therapy at $4-5 mln,Reuters
Nov-23-18,Why Biogen Inc (NASDAQ:BIIB) Looks Like A Quality Company,Simply Wall St.
Nov-23-18,U.S. benefits manager baulks after Novartis values gene therapy at $4-5 million,Reuters
Nov-26-18,Hedge Funds Are Crazy About Biogen Inc. (NASDAQ:BIIB),Insider Monkey
Nov-27-18,Health Care Stocks May Be Safe Haven in Event of Market Downturn,GuruFocus.com
Nov-29-18,How To Trade Growth Stocks: Why Biogen Fell Below Its Buy Point On Breakout Day But Still Won Big,Investor's Business Daily
Nov-29-18,Teva's Rituxan Biosimilar Gets FDA Nod in Non-Hodgkin Lymphoma,Zacks
Nov-30-18,Pfizer Stock Edges Into Buy Zone On AbbVie Deal For Humira Biosimilar,Investor's Business Daily
Dec-03-18,AbbVie Presents Long-Term Data on Cancer Drugs at ASH 2018,Zacks
Dec-04-18,FDA Accepts BLA & Gives Priority Review to Novartis' AVXS-101,Zacks
Dec-06-18,Biogen Exercises Option with Ionis to Develop and Commercialize Investigational Treatment BIIB067 for a Subtype of Familial Amyotrophic Lateral Sclerosis (ALS) Based on Positive Phase 1 Data,GlobeNewswire
Dec-11-18,4 Biotech Stocks Investors Can Add to Their Portfolio in 2019,Zacks
Dec-12-18,5 Pharma Stocks That Could Cure Ailing Portfolios in 2019,InvestorPlace
Dec-12-18,"Biotech Stock Roundup: Gilead to Get New CEO, Biogen In-Licenses Candidate",Zacks
Dec-12-18,"The Zacks Analyst Blog Highlights: Gilead Sciences, Alexion Pharmaceuticals, Regeneron Pharmaceutical and Biogen",Zacks
Dec-13-18,Sell-Side Roundup: What's Next For For Applied Genetic After 50% Plunge?,Benzinga
Dec-13-18,"The Zacks Analyst Blog Highlights: Gilead Sciences, Conatus Pharmaceuticals, Biogen, Ionis Pharmaceuticals and Exelixis",Zacks
Dec-13-18,"The Daily Biotech Pulse: Vivus Extends Supply Deal With Sandoz, Applied Genetic Snaps Ties With Biogen",Benzinga
Dec-14-18,5 Incredible ETFs & Stocks to Buy on the Dip,Zacks
Dec-14-18,5 Drug/Biotech Stocks With Promise to Sustain Bull Run in 2019,Zacks
Dec-17-18,Roche's SMA Candidate Risdiplam Gets PRIME Designation in EU,Zacks
Dec-17-18,Alkermes and Biogen Announce Submission of a New Drug Application to U.S. Food and Drug Administration for Diroximel Fumarate in Multiple Sclerosis,GlobeNewswire
Dec-18-18,Biogen's Slump Is Likely to Continue,TheStreet.com
Dec-18-18,Biotech Stocks Gilead Sciences and Biogen Have Room to Bounce Back,Barrons.com
Dec-18-18,"Alkermes, Biogen Submit NDA to FDA for Multiple Sclerosis Drug",Zacks
Dec-19-18,Today's Research Reports on Trending Tickers: Biogen and Biocept,ACCESSWIRE
Dec-20-18,U.S body says gene therapy may be more cost effective for spinal muscular atrophy,Reuters
Dec-20-18,6 Cheap Stocks Growing Earnings,GuruFocus.com
Dec-20-18,Biogen Applauds Quebec Decision to Cover SPINRAZA (nusinersen) for a broad population of SMA Patients,GlobeNewswire
Dec-20-18,[$$] Pharma Giants Plan Drug Price Hike: Report,The Wall Street Journal
Dec-21-18,Perrigo Tumbles on $1.9 Billion Irish Tax Demand,TheStreet.com
Dec-21-18,Why Gene Therapy Is More Cost Effective Than Biogen's Approved Drug,Investor's Business Daily
Dec-24-18,Perrigo Plunges on $1.9B Tax Bill From Irish Government,Zacks
Dec-26-18,6 Valuable Pipeline Drugs With Upcoming Catalysts,Benzinga
Dec-27-18,The Humira Overhang Cant Cast a Shadow on AbbVie Stock Forever,InvestorPlace
Dec-27-18,Perrigo Stock Up as Appeal Date for Irish Tax Bill Nears,Zacks
Jan-02-19,Biopharmas Restrained In Drug Pricing For 2019  With These Exceptions,Investor's Business Daily
Jan-02-19,Top Picks 2019- Ionis Pharmaceuticals IONS,MoneyShow
Jan-03-19,First Patient Enrolled in Biogens Phase 3b Study to Evaluate Extended Interval Dosing (EID) with Natalizumab in Multiple Sclerosis,GlobeNewswire
Jan-04-19,Biogen Begins Improved Dosing Regimen on Tysabri in Phase III,Zacks
Jan-04-19,"REIT Stocks, Medical Stocks Lead New Buys By The Best Mutual Funds In Down Market",Investor's Business Daily
Jan-04-19,Biogen doubles down on Alzheimer's with new collaboration deal,American City Business Journals
Jan-04-19,Biogen and Skyhawk Therapeutics Announce Agreement to Develop Novel Small Molecule RNA Splicing Modifiers for Neurological Disease Targets,PR Newswire
Jan-04-19,Biogen and C4 Therapeutics Enter into Strategic Collaboration to Discover and Develop Potential New Treatments for Neurological Conditions,GlobeNewswire
Jan-04-19,Are Biogen Inc.s (NASDAQ:BIIB) Interest Costs Too High?,Simply Wall St.
Jan-07-19,Biogen Inks Two Deals to Make Drugs for Neurological Diseases,Zacks
Jan-08-19,The 10 Best Health-Care Stocks to Buy for 2019,Kiplinger
Jan-09-19,Value Added: 7 Top Stocks for 2019,Kiplinger
Jan-09-19,"Biotech Stock Roundup: LOXO, CELG Gain, J.P. Morgan Healthcare Conference in Focus",Zacks
Jan-10-19,Biogen Could Spend Nearly $18 Billion In A Takeover  But Will It?,Investor's Business Daily
Jan-14-19,Will Biogen Jump On This Biotech Stock Amid Buying Spree?,Investor's Business Daily
Jan-16-19,"REIT Stocks, Medical Stocks Lead New Buys By The Best Mutual Funds",Investor's Business Daily
Jan-17-19,Will Biogen (BIIB) Beat Estimates Again in Its Next Earnings Report?,Zacks
Jan-18-19,These 3 Biotech Stocks Appear Poised To Beat Fourth-Quarter Forecasts,Investor's Business Daily
Jan-18-19,Samsung Bioepis-Merck biosimilar to Roche's Herceptin wins FDA nod,Reuters
Jan-18-19,"Top Stock Reports for Pfizer, Biogen & Schwab",Zacks
Jan-24-19,What's Behind the Biotech ETF Rally to Start 2019?,Zacks
Jan-28-19,Biotech is breaking out. Here's what one analyst says to watch ahead of 3 key earnings reports,CNBC
Jan-28-19,"Drug/Biotech Stock Earnings on Jan 29: PFE, AMGN, BIIB &amp; AGN",Zacks
Jan-29-19,"Biotech Giant Outstrips Quarterly Views, Plans New Study In Alzheimer's",Investor's Business Daily
Jan-29-19,Biogen Inc (BIIB) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Jan-29-19,"Biogen (BIIB) Q4 Earnings Beat Estimates, Revenues Up Y/Y",Zacks
Jan-29-19,Biogen beats estimates on multiple sclerosis drugs sales,Reuters
Jan-29-19,Dow Leads Despite Mixed Earnings Results; Apple Earnings On Deck,Investor's Business Daily
Jan-29-19,Biogen (BIIB) Beats Revenues and Earnings Estimates in Q4,Zacks
Jan-29-19,Biogen Stock Running in Place Despite Strong Quarter,Investopedia
Jan-29-19,Biogen stock up 3% after 4Q earnings beat,MarketWatch
Jan-29-19,"UPDATE 1-Biogen beats estimates on Spinraza, Tecfidera strength",Reuters
Jan-29-19,Should Franklin LibertyQ U.S. Equity ETF (FLQL) Be on Your Investing Radar?,Zacks
Jan-29-19,Drugmaker Biogen's fourth-quarter revenue rises 6.6 pct,Reuters
Jan-29-19,"Biogen Inc Earnings, Revenue beat in Q4",Investing.com
Jan-30-19,Edited Transcript of BIIB earnings conference call or presentation 29-Jan-19 1:00pm GMT,Thomson Reuters StreetEvents
Jan-30-19,Biogen Looks to 2020,Motley Fool
Jan-30-19,Stryker Corp's Profit Skyrockets,GuruFocus.com
Jan-30-19,Ionis Wins Price Target Hike On Partner Biogen's Guidance,Benzinga
Jan-30-19,"Biotech Giants Amgen and Biogen Fall on Earnings, Alzheimers News",Barrons.com
Jan-30-19,Roche Scraps Alzheimer's Test  But Investors Punished This Stock,Investor's Business Daily
Jan-31-19,Here are Boston-area biotechs pursuing Parkinson's treatments,American City Business Journals
Feb-01-19,German firm that serves gene therapy biotechs opens Cambridge HQ,American City Business Journals
Feb-01-19,6 Biotech Stocks to Watch Now,Motley Fool
Feb-01-19,How Should You Price Biogen Inc.s (NASDAQ:BIIB) Stock?,Simply Wall St.
Feb-04-19,Alkermes Sinks as FDA Refuses to Approve Depression Drug,Zacks
Feb-06-19,Biogen stock declines as patent office says Mylan patent win likely,MarketWatch
Feb-07-19,Biogen Sheds $5 Billion of Value as Drug Challenge Vexes Street,Bloomberg
Feb-07-19,Why Biogen's 'Battle-Tested' MS Drug Could Win Another Patent Dispute,Investor's Business Daily
Feb-07-19,Biogen Stock Slips on a Setback in a Patent Dispute With Mylan,Barrons.com
Feb-08-19,"Top Research Reports for Visa, Charter Communications & Biogen",Zacks
Feb-11-19,"The Zacks Analyst Blog Highlights: Visa, Charter, Biogen, BP and BB&amp;T",Zacks
Feb-14-19,Alkermes Plc (ALKS) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Feb-14-19,"Despite M&amp;A Spree, Biotech ETFs Slide on Mixed Earnings",Zacks
Feb-14-19,Should You Buy Viking Therapeutics After Gilead Drug Failure?,InvestorPlace
Feb-15-19,Biogen Inc. -- Moody's announces completion of a periodic review of ratings of Biogen Inc.,Moody's
Feb-15-19,Alkermes (ALKS) Q4 Earnings &amp; Revenues Surpass Estimates,Zacks
Feb-19-19,Alkermes Breaks $1 Billion,Motley Fool
Feb-20-19,AbbVie's RA Candidate Upadacitinib Gets FDA Priority Review,Zacks
Feb-21-19,Downgraded Biogen Stock Attracts Options Bears,Schaeffer's Investment Research
Feb-21-19,Stocks - Dow Falls as Dour Data Drowns out Trade Optimism,Investing.com
Feb-21-19,Biogen stock down 1.2% after downgrade by Stifel,MarketWatch
Feb-22-19,"Novartis gene therapy would be cost effective up to $900,000 -U.S. group",Reuters
Feb-22-19,The Top 5 Biotech Stocks Are Facing Growth Challenges  Are Any Immune?,Investor's Business Daily
Feb-25-19,Novartis In-Licenses Rights to Heart Candidate From Ionis,Zacks
Feb-25-19,"Analysis: Positioning to Benefit within Biogen, Mirati Therapeutics, PLDT, Zebra Technologies, Domino's Pizza, and Solar Capital  Research Highlights Growth, Revenue, and Consolidated Results",GlobeNewswire
Feb-25-19,Alkermes and Biogen Announce U.S. Food and Drug Administration Acceptance of Diroximel Fumarate New Drug Application for Multiple Sclerosis,GlobeNewswire
Feb-26-19,Alkermes' (ALKS) and Biogen's NDA for BIIB098 Accepted by FDA,Zacks
Feb-27-19,Ionis Pharmaceuticals (IONS) Q4 2018 Earnings Conference Call Transcript,Motley Fool
Feb-27-19,Here's Why Ionis Pharmaceuticals Jumped Higher Today,Motley Fool
Feb-28-19,8 High Margin Stocks to Lead in a Sharply Slowing Economy,Investopedia
Mar-01-19,Biogen Responds to CADTHs updated recommendation regarding coverage for SPINRAZA,GlobeNewswire
Mar-04-19,Stock Market Today: Biogen Buys Gene Therapy Company Nightstar Therapeutics,Motley Fool
Mar-04-19,Biogen Shores Up Gene Therapy Assets With $800 Million Takeover,Investor's Business Daily
Mar-04-19,Ionis Pharmaceuticals Funds Its Pipeline of More Than 40 Drugs,Motley Fool
Mar-04-19,"NITE, BIIB: Nightstar Therapeutics Stock Soars on Biogen Buy",InvestorPlace
Mar-04-19,Nightstar Stock Is Latest Winner From Gene-Therapy Gold Rush,Barrons.com
Mar-04-19,Biogen Buys Nightstar Therapeutics in $800 Million Deal,GuruFocus.com
Mar-04-19,Can You Imagine How Biogens Shareholders Feel About The 24% Share Price Increase?,Simply Wall St.
Mar-04-19,Biogen Makes Gene Therapy Splash as Street Wonders What's Next,Bloomberg
Mar-04-19,AbbVie Gets CHMP Nod for Psoriasis Candidate Risankizumab,Zacks
Mar-04-19,Why Nightstar Therapeutics Stock Is Soaring Today,Motley Fool
Mar-04-19,Nightstar Soars as Biogen to Buy Gene Therapy Company for $877 Million,TheStreet.com
Mar-04-19,"Biogen Bets On Gene Therapy, Agrees To Acquire Nightstar For $800M",Benzinga
Mar-04-19,Nightstar Therapeutics' stock rockets on Biogen buyout deal valued at $877 million,MarketWatch
Mar-04-19,[$$] Biogen Buys Gene Therapy for Rare Eye Disease,The Wall Street Journal
Mar-04-19,"Stocks - Tesla, AT&T, Amazon, Facebook Rise in Premarket",Investing.com
Mar-04-19,Biogen to buy Nightstar Therapeutics in $800 mln cash deal,Reuters
Mar-04-19,Biogen Announces Agreement to Acquire Nightstar Therapeutics to Establish Clinical Pipeline of Gene Therapy Candidates in Ophthalmology,GlobeNewswire
Mar-05-19,Biogen to Acquire Gene-Therapy Company Nightstar for $800M,Zacks
Mar-05-19,How Much Does Biogen Gain From Its $800 Million Gene Therapy Buyout?,Investor's Business Daily
Mar-05-19,Analysts Laud Biogen's M&A Strategy Following Deal to Buy Gene Therapy Company Nightstar,Benzinga
Mar-05-19,"Company News For Mar 5, 2019",Zacks
Mar-06-19,"Biotech Stock Roundup: BIIB to Acquire Nightstar, Other Pipeline News &amp; More",Zacks
Mar-06-19,Biotech Companies Slump Midday With FDA Chief Set to Leave,Investing.com
Mar-08-19,6 of the Most Expensive Stocks That Could Go On Sale,InvestorPlace
Mar-08-19,Gene Therapy M&A Has Shares Skyrocketing -- Could This Company Be Next?,Motley Fool
Mar-11-19,Mass. firms riding bull market to nearly $1 trillion in gains,American City Business Journals
Mar-12-19,"Top Stock Reports for Visa, Honeywell & Biogen",Zacks
Mar-12-19,"Fujifilm snaps up Biogen manufacturing site, employees for $890M",American City Business Journals
Mar-12-19,Celgene (CELG) Submits Application for MS Drug in Europe,Zacks
Mar-12-19,Japan's Fujifilm buys biologics unit from Biogen to boost healthcare business,Reuters
Mar-13-19,"The Zacks Analyst Blog Highlights: Visa, Honeywell, Biogen, Humana and EOG Resources",Zacks
Mar-14-19,"Top Stock Reports for Visa, Honeywell & Biogen",Zacks
Mar-15-19,"PDL BioPharma (PDLI) Q4 Earnings Top Mark, Revenues Fall Y/Y",Zacks
Mar-18-19,Biogen Could Go Either Way - Mixed Indicators and Charts,TheStreet.com
Mar-21-19,Eisai shares untraded after ending Alzheimer drug trials,Reuters
Mar-21-19,The S&P 500 Eked Out a Gain Despite Biogens 29% Plunge,Barrons.com
Mar-21-19,S&P 500 ends 2-day losing streak as tech leads stocks higher,Associated Press
Mar-21-19,Stock Market Today: Biogen Crushed After Failure of Alzheimer's Drug,Motley Fool
Mar-21-19,Is Biogen a Bad-News Buy Now?,Motley Fool
Mar-21-19,"Biogen scraps two Alzheimer drug trials, wipes $18 billion from market value",Reuters
Mar-21-19,Biogen analyst breaks down what investors want from the c...,CNBC Videos
Mar-21-19,"US STOCKS-Wall Street rises as Apple, tech shares climb",Reuters
Mar-21-19,Biogen and Guess slide while Darden and Micron rise,Associated Press
Mar-21-19,Biogen Crashes On Alzheimer's Flop  Is Its Remaining Pipeline A Dud?,Investor's Business Daily
Mar-21-19,Dow Ends Solidly Higher as Investors Shrug Off Fed Warning of Slowing Growth,TheStreet.com
Mar-21-19,"Biogen halted trial could boost M&A activity, says analys...",CNBC Videos
Mar-21-19,Biogen shares tank on scrapping Alzheimer trials,Reuters Videos
Mar-21-19,Biogen: Don't Look a Gift Horse in the Mouth,GuruFocus.com
Mar-21-19,"Biogen scraps two Alzheimer drug trials, wipes $18 billion from market value",Reuters
Mar-21-19,Mass. investment firms see one-day loss of $1.7B in Biogen's Alzheimer's drug flop,American City Business Journals
Mar-21-19,"Biogen scraps two Alzheimer drug trials, wipes $18 billion from market value",Reuters
Mar-21-19,US STOCKS-Tech dominates Wall Street rally in wake of dovish Fed statement,Reuters
Mar-21-19,Investors should have known better to blame Biogen for Al...,CNBC Videos
Mar-21-19,Should You Buy the Biogen Dip?,TheStreet.com
Mar-21-19,Biogen Shares Plunge After Alzheimers Drug Setback,Bloomberg
Mar-21-19,Biogen May Shed $18 Billion in Value After Scrapping Alzheimer's Drug Trial,TheStreet.com
Mar-21-19,US STOCKS-Tech powers Wall Street's recovery; banks reel under Fed's dovish stance,Reuters
Mar-21-19,Here's Who May Have Been Crushed in Biogen's $18 Billion Plunge,Bloomberg
Mar-21-19,"Stocks making the biggest moves midday: Levi Strauss, Biogen, Micron & more",CNBC
Mar-21-19,The Biogen Stock Plunge Looks a Lot Like the Notorious Marlboro Friday,Barrons.com
Mar-21-19,"The Late Morning Rundown: March 21, 2019",CNBC Videos
Mar-21-19,What's Next for Biogen After Its Alzheimer's Disease Drug Flop?,Motley Fool
Mar-21-19,"Jim Cramer's Thoughts on Micron, Biogen, Apple and Tesla",TheStreet.com
Mar-21-19,Volatile Biogen Stock Plunges $90: Here's the Trade I'm Considering,TheStreet.com
Mar-21-19,Biogens Big Bet in Alzheimers Disease Is a Bust,Motley Fool
Mar-21-19,US STOCKS-Wall St gains as tech boost offsets bank losses after Fed stance,Reuters
Mar-21-19,"Jobless Claims Dip, Philly Fed Swings, Biogen (BIIB) Plummets",Zacks
Mar-21-19,Biogen stock plummets 28% after company halts Alzheimers trials,MarketWatch
Mar-21-19,"Stock Market News: Biogen Bombs, but Micron Moves Higher",Motley Fool
Mar-21-19,Why Biogen Stock Is Crashing Today,Motley Fool
Mar-21-19,US STOCKS-Wall St edges higher as tech boost counters losses in bank stocks,Reuters
Mar-21-19,"Dow Jones, Stock Market Rally; Biotech Giant Plunges On Canceled Trial",Investor's Business Daily
Mar-21-19,Initial Jobless Claims Decline,Zacks
Mar-21-19,"Jobless Claims Dip, Philly Fed Swings, Biogen (BIIB) Plummets",Zacks
Mar-21-19,"Alkermes Focuses on Pipeline, Depends on Partners for Funds",Zacks
Mar-21-19,Biogen halted its Alzheimer's drug trial. Here's what tha...,CNBC Videos
Mar-21-19,"Jim Cramer Breaks Down Micron, Biogen and Apple - LIVE",TheStreet.com
Mar-21-19,Stocks attempt post-Fed bounce as Wall digests dovish stance; Levi Strauss set for its IPO,MarketWatch
Mar-21-19,"Stocks Slip, Then Reverse; Nasdaq Leads: Apple Climbs On Upgrade",Investor's Business Daily
Mar-21-19,What's Next for Biogen After It Terminates Trials for Alzheimer's Drug?,TheStreet.com
Mar-21-19,Biogen Stock Is Plunging Because Its Alzheimers Treatment Failed,Barrons.com
Mar-21-19,US STOCKS-Wall St set for lower open after Fed's abrupt dovish turn,Reuters
Mar-21-19,"Here are the biggest analyst calls of the day: Biogen, Apple, Micron, & more",CNBC
Mar-21-19,Biogen shares fall after it scraps Alzheimer's treatment,CNBC Videos
Mar-21-19,"Stocks making the biggest moves premarket: Biogen, Boeing, Walmart, Apple, Clorox & more",CNBC
Mar-21-19,Biogen shares plunge nearly 30% after ending trial for potential blockbuster Alzheimer's drug,CNBC
Mar-21-19,Biogen's stock plummets after phase 3 trial of Alzheimer's treatment discontinued,MarketWatch
Mar-21-19,"Biogen scraps Alzheimer's trial, shares skid",Reuters
Mar-21-19,Biogens Alzheimers Drug Flop Could Wipe Out a Third of Value,Bloomberg
Mar-21-19,"Biogen, Eisai scrap Alzheimer drug trials",Reuters
Mar-21-19,Biogen and Eisai to Discontinue Phase 3 ENGAGE and EMERGE Trials of aducanumab in Alzheimers Disease,GlobeNewswire
Mar-22-19,PRIMECAP's Biogen Exposure Could Be History Repeating,Morningstar
Mar-22-19,Biogen Skids On Alzheimer's Flop  And Unveils Yet Another Study,Investor's Business Daily
Mar-22-19,"Current Stock Market Reverses Lower But Apple, Amazon Strong; Boeing 737 Max Probe; Biogen Dives: Weekly Review",Investor's Business Daily
Mar-22-19,Analysts Digest Biogen's Alzheimer's Disappointment: 'There Isn't Much To Be Excited About',Benzinga
Mar-22-19,Biogen Stock Is Falling Again Because Even a Massive Plunge Doesnt Make it a Bargain Buy,Barrons.com
Mar-22-19,Biogen Stock Crashes on Termination of Alzheimer's Studies,Zacks
Mar-22-19,Biogen Stock Fell Too Far on Unfortunate News,InvestorPlace
Mar-22-19,"Company News For Mar 22, 2019",Zacks
Mar-22-19,PMN.TO: Aducanumab Failed. What Does This Mean for Amyloid Beta?,Zacks Small Cap Research
Mar-22-19,Eisai Launches Confirmatory Late-Stage Trial Of Second Alzheimer's Asset After Setback,Benzinga
Mar-22-19,Biogen stock price target cut to $247 from $341 at SVB Leerink,MarketWatch
Mar-22-19,"Biogen stock plunge shows 'investment model in drug development is all wrong,' says former Atena CEO",CNBC
Mar-22-19,Biogen stock downgraded to neutral from buy at UBS,MarketWatch
Mar-22-19,Former Aetna CEO Mark Bertolini on 'Medicare for All': No...,CNBC Videos
Mar-25-19,Dow Ends Slightly Higher Despite Slowing Global Growth Worries,TheStreet.com
Mar-25-19,3 Top Healthcare Stocks to Buy Right Now,Motley Fool
Mar-25-19,1 Surprising Reason Alzheimer's Drugs Remain So Elusive,Motley Fool
Mar-25-19,"Dow Jones Recovers After 130-Point Drop; Marijuana Stocks Rally, Led By Cronos Group",Investor's Business Daily
Mar-25-19,"Biogen Stock Likely Wont See a Boost From Buybacks, Analysts Say",Barrons.com
Mar-25-19,Biogen announces $5 billion buyback days after shelving Alzheimer's trials,Reuters
Mar-25-19,Biogen Announces $5 Billion Buyback Just Days After Stock Plunge,TheStreet.com
Mar-25-19,"Avon and Biogen Gain, and 3 Other Stocks Making Moves",Barrons.com
Mar-25-19,5 biotech stocks that could be the next big winners,MarketWatch
Mar-25-19,Biogen announces $5 billion buyback days after shelving Alzheimer's trials,Reuters
Mar-25-19,Biogen sets new $5 billion stock repurchase program in aftermath of stock plunge,MarketWatch
Mar-25-19,Biogen stock plummets 28% after company halts Alzheimers trials,MarketWatch
Mar-25-19,"Stocks - Viacom Jumps in Premarket, Nike, Apple Drop, Boeing Gains",Investing.com
Mar-26-19,Celgene (CELG) Submits NDA for MS Drug to FDA for Review,Zacks
Mar-26-19,"Why Viacom, Ferroglobe, and Biogen Jumped Today",Motley Fool
Mar-26-19,"Stocks - Dow Ends Higher, but Gains Capped by Weak Economic Data",Investing.com
Mar-26-19,AbbVie's Psoriasis Drug Skyrizi Gets First Approval in Japan,Zacks
Mar-26-19,Biogen's Bad News for Everyone,Motley Fool
Mar-26-19,"Detailed Research: Economic Perspectives on Biogen, Invesco, Bunge, Concho Resources, Maximus, and Meredith  What Drives Growth in Today's Competitive Landscape",GlobeNewswire
Mar-27-19,The 5 Worst-Performing Stocks in the S&P 500 in 2019,GuruFocus.com
Mar-27-19,"3 High-Quality, Low Price-Earnings Companies Broadly Owned by Gurus",GuruFocus.com
Mar-27-19,Is Biogen Inc. (BIIB) A Good Stock To Buy?,Insider Monkey
Mar-27-19,Novartis (NVS) Receives FDA Approval for MS Drug Mayzent,Zacks
Mar-27-19,The Hits Just Keep Coming For Biogen As Rival Gains MS Drug Approval,Investor's Business Daily
Mar-27-19,"Biotech Stock Roundup: BIIB &amp; CNAT Crash on Study Failures, LXRX Gets CRL",Zacks
Mar-27-19,Future Brightens for 2 Small Biotech Stocks,TheStreet.com
Mar-27-19,Biogen Remains a Wide-Moat Neurology Innovator,Morningstar
Mar-27-19,Biogen- A Bad News Biotech Buy,MoneyShow
Mar-28-19,Is Biogen a Beat-Up Bargain? And Is Bristol-Myers' Mega-Merger on the Rocks?,Motley Fool
Mar-28-19,Why Biogen's Alzheimer's Drug Failure May Have a Silver Lining,Motley Fool
Mar-29-19,Are the health care stocks flat lining? Here are the beaten down names traders are still buying,CNBC Videos
Mar-29-19,4 Small Biotech Stocks Likely to Witness More Upside in 2019,Zacks
Apr-01-19,Celgene Gets Positive CHMP Nod for Revlimid Label Expansion,Zacks
Apr-01-19,These are the 20 most valuable brands in Massachusetts,American City Business Journals
Apr-01-19,3 High Earnings-Yield Stocks,GuruFocus.com
Apr-01-19,Merck KgaA's (MKGAF) MS Drug Mavenclad Gets FDA Approval,Zacks
Apr-02-19,3 Healthcare Stocks to Trade Now,InvestorPlace
Apr-02-19,Will Biogen (BIIB) Beat Estimates Again in Its Next Earnings Report?,Zacks
Apr-03-19,"Biogen SMA drug price, Novartis estimates for its treatment far too high: U.S. group",Reuters
Apr-03-19,"Biogen SMA drug price, Novartis estimates for its treatment far too high -U.S. group",Reuters
Apr-03-19,"Biogen SMA drug price, Novartis estimates for its treatment far too high -U.S. group",Reuters
Apr-03-19,Why Nightstar Therapeutics Stock Skyrocketed 71% in March,Motley Fool
Apr-04-19,Here's What Biogen Inc.'s (NASDAQ:BIIB) P/E Ratio Is Telling Us,Simply Wall St.
Apr-04-19,1 Biotech That Biogen Should Buy ... but Probably Won't,Motley Fool
Apr-04-19,Buy Biogen on the dip? What about AMC on the streaming wars? The viewers #AskHalftime,CNBC Videos
Apr-04-19,Why Biogen Stock Tanked in March,Motley Fool
Apr-04-19,MOVES-Activist hedge fund Sarissa hires president in push for growth,Reuters
Apr-09-19,Biogen (BIIB) Dips More Than Broader Markets: What You Should Know,Zacks
Apr-09-19,6 Predictable Guru Stocks,GuruFocus.com
Apr-10-19,"Raymond James: Biogen's Business Appears Fragile, Faces Many Headwinds",Benzinga
Apr-11-19,"Risk-Tolerant Investors, Turn Your Eyes to Exelixis Stock",InvestorPlace
Apr-12-19,Biogen Continues to Advance Innovation in SMA with New Data in Adults and Infants to Be Presented at MDA Clinical and Scientific Conference,GlobeNewswire
Apr-15-19,Biogen (BIIB) Dips More Than Broader Markets: What You Should Know,Zacks
Apr-15-19,"Seeking $86 million IPO, this Peninsula company is betting common bacteria plays role in Alzheimer's",American City Business Journals
Apr-17-19,Here's Why Ionis Pharmaceuticals Slumped Today,Motley Fool
Apr-17-19,2 Beaten Down Bluechips: Are They Buys?,Motley Fool
Apr-17-19,Biogen (BIIB) Reports Next Week: Wall Street Expects Earnings Growth,Zacks
Apr-18-19,Roche's (RHHBY) Q1 Sales Strong on Solid Demand for New Drugs,Zacks
Apr-22-19,Better Buy: Biogen vs. AbbVie,Motley Fool
Apr-22-19,Biogen (BIIB) to Report Q1 Earnings: What's in the Cards?,Zacks
Apr-22-19,Will Bristol-Myers (BMY) Disappoint This Earnings Season?,Zacks
Apr-22-19,Patients living with Spinal Muscular Atrophy (SMA) in the province of Saskatchewan gain access to SPINRAZA (nusinersen),CNW Group
Apr-23-19,"You can find plenty of solid stock bargains in this years worst-performing sector, analyst says",MarketWatch
Apr-23-19,Health-care earnings: Medicare for all looms large,MarketWatch
Apr-23-19,What's in Store for Celgene Corporation (CELG) Q1 Earnings?,Zacks
Apr-23-19,Biogen Reports Earnings Tomorrow. Heres What to Expect.,Barrons.com
Apr-24-19,Edited Transcript of BIIB earnings conference call or presentation 24-Apr-19 12:00pm GMT,Thomson Reuters StreetEvents
Apr-24-19,Biogen Won't Disavow Its Alzheimer's Goal  So What's Next For Growth?,Investor's Business Daily
Apr-24-19,Biogen Inc (BIIB) Q1 2019 Earnings Call Transcript,Motley Fool
Apr-24-19,Biogen says it will not give up on Alzheimers after failed trials,MarketWatch
Apr-24-19,Biogen Earnings: BIIB Stock Slips Despite Q1 Beat,InvestorPlace
Apr-24-19,"Stocks making the biggest moves midday: AT&T, Domino's Pizza, eBay & more",CNBC
Apr-24-19,"Biogen (BIIB) Beats on Q1 Earnings, Spinraza Drives Sales",Zacks
Apr-24-19,Biogen dips as strategy post Alzheimer's setback fails to impress,Reuters
Apr-25-19,Jerome Dodson's 1st Quarter Parnassus Endeavor Fund Commentary,GuruFocus.com
Apr-25-19,Biogen Looks to 23 Clinical Programs for Growth,Motley Fool
Apr-25-19,Bitcoin and Biogen among the second round 2019 Stock Draft picks,CNBC Videos
Apr-25-19,"Here is who's competing in the 2019 Stock Draft, the rules and the first pick",CNBC Videos
Apr-25-19,IPO Cortexyme Hopes to Succeed in Alzheimer's Where Giants like Biogen Have Failed,GuruFocus.com
Apr-25-19,Edited Transcript of BIIB earnings conference call or presentation 24-Apr-19 12:00pm GMT,Thomson Reuters StreetEvents
Apr-25-19,"AbbVie says Humira rivals from Biogen, Amgen most aggressive so far",Reuters
Apr-25-19,"AbbVie says Humira rivals from Biogen, Amgen most aggressive so far",Reuters
Apr-25-19,Biogen says it will not give up on Alzheimers after failed trials,MarketWatch
Apr-26-19,Is This Highly-Anticipated Gene Therapy in Trouble?,Motley Fool
Apr-26-19,Alkermes Looks Ahead to Growth,Motley Fool
Apr-26-19,"Cramer's Takeaways for Ford, Chevron, Alibaba, Biogen, Visa",TheStreet.com
Apr-26-19,Alkermes (ALKS) Reports Narrower-Than-Expected Loss in Q1,Zacks
Apr-26-19,Analysts point to potential Biogen M&A options after Alzheimer's failure,American City Business Journals
Apr-29-19,Biogen Announces Three New Nominees for Election to Board of Directors,GlobeNewswire
Apr-30-19,3 Tech Stocks for Growth Investors to Buy Right Now,Zacks
Apr-30-19,Biogen Is 3 Adding Directors. Investors Might Question Whether Thats Bold Enough.,Barrons.com
Apr-30-19,10 Workhorse Health Care Stocks That Never Break a Sweat,Kiplinger
Apr-30-19,The 10 Best Health Care Stocks to Buy for 2019,Kiplinger
May-01-19,Biogen to Present New Interim Data from Its Phase 1/2 Clinical Study of Tofersen (BIIB067) for the Potential Treatment of a Subtype of Familial Amyotrophic Lateral Sclerosis (ALS),GlobeNewswire
May-01-19,"David Carlson Buys 2 Stocks, Sells 1 in 1st Quarter",GuruFocus.com
May-01-19,"Biotech Stock Roundup: BIIB, VRTX, ALXN Q1 Earnings Top &amp; Other Pipeline Updates",Zacks
May-01-19,What's in the Cards for Sunesis (SNSS) This Earnings Season?,Zacks
May-01-19,Biogen To Present Data At AAN Highlighting Its Innovative Marketed Treatments And Investigational Pipeline Programs For Complex Neurodegenerative Diseases,GlobeNewswire
May-02-19,These 6 biotech stocks are promising takeover targets,MarketWatch
May-02-19,"The Zacks Analyst Blog Highlights: Biogen, Celgene, Incyte, Alexion and Vertex",Zacks
May-02-19,"Betting Against Biogen Stock Might Be Fashionable, but Its a Mistake, Analyst Says",Barrons.com
May-02-19,What Do Analysts Think About Biogen Inc.'s (NASDAQ:BIIB) Future?,Simply Wall St.
May-02-19,"The Daily Biotech Pulse: FDA Nod For Sanofi's Dengue Vaccine, Veracyte Offering, Biogen Reports Positive Data",Benzinga
May-06-19,Jerome Dodson Comments on Biogen,GuruFocus.com
May-06-19,Weekly CEO Buys Highlight,GuruFocus.com
May-06-19,"Notable Insider Buys This Past Week: ADM, Biogen, Grubhub and More",Benzinga
May-07-19,Biotech ETFs in Focus on String of Q1 Earnings Beats,Zacks
May-07-19,This Biotech Has A 'Swing Factor' In SMA Drugs And It's Slugging Biogen,Investor's Business Daily
May-07-19,Data at AAN Demonstrate Biogens Leadership and Commitment to Innovation in MS,GlobeNewswire
May-08-19,"Parnassus Endeavor Fund Buys AbbVie, Boosts Biogen",GuruFocus.com
May-08-19,Jeff Auxier Comments on Biogen,GuruFocus.com
May-08-19,Jeff Auxier's 1st Quarter Auxier Focus Fund Shareholder Letter,GuruFocus.com
May-09-19,Stock Buybacks Surge,Kiplinger
May-10-19,"PDL BioPharma (PDLI) Q1 Earnings Top Mark, Revenues Rise Y/Y",Zacks
May-10-19,Alzheimer's Clinical Trials Consortium Selects Elenbecestat and BAN2401 for Upcoming Clinical Studies on Prevention of Alzheimer's Disease,PR Newswire
May-13-19,Dr. Reddy's (RDY) to Report Q4 Earnings: What's in Store?,Zacks
May-13-19,Alzheimer's Clinical Trials Consortium Selects Elenbecestat and BAN2401 for Upcoming Clinical Studies on Prevention of Alzheimer's Disease,PR Newswire
May-14-19,"NHS England, Biogen reach deal on pricey drug for deadly disorder",Reuters
May-14-19,"NHS England, Biogen reach deal on pricey drug for deadly disorder",Reuters
May-15-19,"Stocks making the biggest moves premarket: Alibaba, Zillow Group, Biogen, McDonald's, Beyond Meat & more",CNBC
May-15-19,"The Daily Biotech Pulse: FDA Greenlights Pfizer-Merck KGAa's Kidney Cancer Combo Treatment, Adcom Disappointment For Daiichi",Benzinga
May-15-19,5 Low Price-to-Book Value Stocks for Great Returns,Zacks
May-16-19,"Wayfair cracks Fortune 500 list, joins 15 other Mass. companies",American City Business Journals
May-16-19,Big Biotech Needs Big M&A to Boost Their Beaten-Down Stocks,Barrons.com
May-17-19,"Celgene Gets EC Nod for Label Expansion of Revlimid, Imnovid",Zacks
May-20-19,Biogen Urges Shareholders To Reject Low-Ball Mini-Tender Offer,Investor's Business Daily
May-20-19,Biogen urges shareholders to reject 'below-market' mini-tender offer from TRC Capital,MarketWatch
May-20-19,Biogen Recommends Stockholders Reject the Below-market Mini-tender Offer by TRC Capital Corporation,GlobeNewswire
May-21-19,"The Best and Worst Big Biotech Stocks, According to One Analyst",Barrons.com
May-21-19,"We don't yet have the technology to cure Alzheimer's, health-care investor says",CNBC
May-21-19,"Apple, Biogen, Diamondback Energy and More: Why These Stocks Are Trending",Insider Monkey
May-22-19,3 Tech Stocks for Growth Investors to Buy Right Now,Zacks
May-22-19,"Top Research Reports for Chubb, Las Vegas Sands & Biogen",Zacks
May-22-19,"Biotech Stock Roundup: Label Expansion for CELG's Drugs, Setback for IMGN",Zacks
May-22-19,"The Best and Worst Big Biotech Stocks, According to One Analyst",Barrons.com
May-23-19,Preclinical biotech Stoke Therapeutics plans $86M IPO,American City Business Journals
May-23-19,"Earnings Preview: Veeva (VEEV), Palo Alto Networks (PANW), Workday (WDAY)",Zacks
May-23-19,The Patient View: Biogen Alzheimer's Trial Participant Jeff Borghoff at Healthy Returns,CNBC Videos
May-23-19,"The Zacks Analyst Blog Highlights: Chubb, Las Vegas Sands, Biogen, Dollar General and Canadian Pacific",Zacks
May-23-19,"Wedbush Securities Senior Vice President of Equity Research Laura Chico, Ph.D. Initiates Coverage on Six Stocks in the Healthcare and BioTech Space - ACER, ACOR, ALNX, BIIB, DOVA and SAGE",PR Newswire
May-23-19,"The top-performing hedge funds are buying GE, Facebook, Biogen and these other stocks",CNBC
